Zolpidem Tartrate Tablet, Film Coated, Extended Release
Product Images NDC 72162-2441

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 72162-2441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of Zolpidem Tartrate, showing the molecular arrangement of the Zolpidem moiety complexed with tartaric acid. The diagram includes two Zolpidem units and the tartaric acid component on the right.*

FDA Label Image

Figure1 (Figure1)

A line graph depicting mean plasma concentration-time profiles comparing Zolpidem Tartrate extended-release tablets (12.5 mg) and immediate-release tablets (10 mg). The x-axis shows time in hours from 0 to 8, and the y-axis indicates zolpidem plasma concentrations in ng/mL from 0 to 120. Two curves illustrate the concentration changes over time for each formulation.*

FDA Label Image

Label (Lbl721622441)

Label for Zolpidem Tartrate Extended-Release Tablets USP 12.5 mg, a film-coated bi-layer oral tablet. The label shows the NDC 72162-2441-1 and indicates packaging of 100 tablets. It is relabeled by Bryant Ranch Prepack and manufactured by Sun Pharmaceutical Industries Ltd. Storage instructions and dispensing warnings are also included along with QR codes for package insert and medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.